Lokki ML - Search Results

1

Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.

Kotilainen H, Lokki ML, Paakkanen R, Seppänen M, Tukiainen P, Meri S, Poussa T, Eskola J, Valtonen V, Järvinen A. Kotilainen H, et al. Among authors: lokki ml. PLoS One. 2014 Mar 17;9(3):e91450. doi: 10.1371/journal.pone.0091450. eCollection 2014. PLoS One. 2014. PMID: 24638111 Free PMC article.

2

Clinical features of patients with homozygous complement C4A or C4B deficiency.

Liesmaa I, Paakkanen R, Järvinen A, Valtonen V, Lokki ML. Liesmaa I, et al. Among authors: lokki ml. PLoS One. 2018 Jun 21;13(6):e0199305. doi: 10.1371/journal.pone.0199305. eCollection 2018. PLoS One. 2018. PMID: 29928053 Free PMC article.

3

Beneficial effect of clarithromycin in patients with acute coronary syndrome and complement C4 deficiencies.

Paakkanen R, Palikhe A, Seppänen M, Nieminen MS, Vauhkonen H, Saikku P, Lokki ML, Sinisalo J. Paakkanen R, et al. Among authors: lokki ml. Scand Cardiovasc J. 2009 Dec;43(6):395-401. doi: 10.1080/14017430902874305. Scand Cardiovasc J. 2009. PMID: 19365786 Free article. Clinical Trial.

4

Complement C4 deficiency and HLA homozygosity in patients with frequent intraoral herpes simplex virus type 1 infections.

Seppänen M, Lokki ML, Timonen T, Lappalainen M, Jarva H, Järvinen A, Sarna S, Valtonen V, Meri S. Seppänen M, et al. Among authors: lokki ml. Clin Infect Dis. 2001 Nov 1;33(9):1604-7. doi: 10.1086/323462. Epub 2001 Sep 26. Clin Infect Dis. 2001. PMID: 11577377

5

Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.

Paakkanen R, Vauhkonen H, Eronen KT, Järvinen A, Seppänen M, Lokki ML. Paakkanen R, et al. Among authors: lokki ml. PLoS One. 2012;7(6):e38813. doi: 10.1371/journal.pone.0038813. Epub 2012 Jun 21. PLoS One. 2012. PMID: 22737222 Free PMC article.

6

Diversity of extended HLA-DRB1 haplotypes in the Finnish population.

Wennerström A, Vlachopoulou E, Lahtela LE, Paakkanen R, Eronen KT, Seppänen M, Lokki ML. Wennerström A, et al. Among authors: lokki ml. PLoS One. 2013 Nov 21;8(11):e79690. doi: 10.1371/journal.pone.0079690. eCollection 2013. PLoS One. 2013. PMID: 24278156 Free PMC article.

7

Novel Associations Between Major Histocompatibility Complex and Pediatric-onset Inflammatory Bowel Disease.

Kolho KL, Paakkanen R, Lepistö A, Wennerstöm A, Meri S, Lokki ML. Kolho KL, et al. Among authors: lokki ml. J Pediatr Gastroenterol Nutr. 2016 Apr;62(4):567-72. doi: 10.1097/MPG.0000000000000984. J Pediatr Gastroenterol Nutr. 2016. PMID: 26398154

8

The complexity and diversity of major histocompatibility complex challenge disease association studies.

Lokki ML, Paakkanen R. Lokki ML, et al. HLA. 2019 Jan;93(1):3-15. doi: 10.1111/tan.13429. Epub 2018 Dec 20. HLA. 2019. PMID: 30468004 Review.

9

Subtly impaired humoral immunity predisposes to frequently recurring genital herpes simplex virus type 2 infection and herpetic neuralgia.

Seppanen M, Meri S, Notkola IL, Seppala IJ, Hiltunen-Back E, Sarvas H, Lappalainen M, Valimaa H, Palikhe A, Valtonen VV, Lokki ML. Seppanen M, et al. Among authors: lokki ml. J Infect Dis. 2006 Sep 1;194(5):571-8. doi: 10.1086/506477. Epub 2006 Jul 24. J Infect Dis. 2006. PMID: 16897653

10

Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events.

Palikhe A, Sinisalo J, Seppänen M, Haario H, Meri S, Valtonen V, Nieminen MS, Lokki ML. Palikhe A, et al. Among authors: lokki ml. Am J Cardiol. 2007 Apr 1;99(7):890-5. doi: 10.1016/j.amjcard.2006.11.034. Epub 2007 Feb 9. Am J Cardiol. 2007. PMID: 17398178

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters